41 – 48 of 48
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes and mild hyperglycaemia
(
- Contribution to journal › Article
-
Mark
Excessive islet NO generation in type 2 diabetic GK rats coincides with abnormal hormone secretion and is counteracted by GLP-1.
(
- Contribution to journal › Article
- 2007
-
Mark
Pathophysiology and treatment of defective insulin secretion in diabetes
2007)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Improved meal-related insulin processing contributes to the enhancement of B-Cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes
(
- Contribution to journal › Article
- 2006
-
Mark
Vildagliptin: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties.
(
- Contribution to journal › Article
- 2005
-
Mark
Alpha cell function in health and disease: influence of glucagon-like peptide-1
(
- Contribution to journal › Scientific review
- 2004
-
Mark
Insulin feedback actions: complex effects involving isoforms of islet nitric oxide synthase.
(
- Contribution to journal › Article
- 1997
-
Mark
Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors
(
- Contribution to journal › Article